NEW YORK – A new genome-wide association study led by University of Edinburgh investigators suggests genes that contribute to antiviral and inflammatory functions of the immune system may mediate COVID-19 disease severity in individuals from the UK, offering an avenue for developing, testing, and tailoring treatment options.